Clinical Trial

Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical trial evaluating the efficacy and safety of GZR18 injection in obese subjects with moderate to severe obstructive sleep apnea who are unable or unwilling to undergo positive airway pressure (PAP) therapy.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-03-27
Trial Details
NCT Number NCT07493057
Lead Sponsor Gan & Lee Pharmaceuticals.
Conditions Obstructive Sleep Apnea (OSA)
Enrollment 140 participants
Start Date 2026-04-27
Primary Completion 2027-11-14 (estimated)
Study Completion 2027-11-14 (estimated)
Updated on ClinicalTrials.gov 2026-03-27